Alec Mian

Previously, Dr. Mian was CEO and a co-founder of Genmedica Therapeutics SL, a biotechnology company founded in 2005 in Barcelona, Spain to develop therapeutics for metabolic diseases such as type 2 diabetes. Under Dr. Mian’s leadership, Genmedica developed one of the few novel approaches for developing drugs that target disease pathogenesis rather than just symptoms. Using this approach Genmedica became one of Spain’s leading biotechnology startups, closing Spain’s largest life-science financing round in 2012. Genmedica’s compounds are currently in phase II clinical trials. Between 2000 to 2005, Dr. Mian founded and directed the design company La Evolution Barcelona SL with a small group of designers and marketing professionals. La Evolucion sold interior high-end illumination coupled with a variety of graphic designs, globally to both public and private spaces. Dr. Mian was also a member of the Board of Directors of Santa & Cole, Spain's largest design company. Before that, Alec Mian was CEO and co-founder of Gamera Biosciences Corporation in Boston, USA which was founded in 1993 to develop high-speed, microfluidics technology for the drug discovery and genomics industries. The company was financed by local and international venture capital sources. In 1999 Gamera was sold to Tecan Ltd (SWX: TECN), a publicly-traded Swiss biomedical company. Dr. Mian completed his Bachelors in biology at McGill University in Montreal, Canada. He completed his doctorate in genetics at University of Cambridge, UK, with Dr. Gabriel Dover; and Harvard Medical School, Boston, USA, with Dr. George Church. He is author or co-author of dozens patents and publications. Dr. Mian is a citizen of Germany and Canada.